Skip to main content

EyePoint, Inc.

EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
SEC CIK
0001314102

In the last 90 days, EyePoint, Inc. insiders filed 1 open-market purchase and 1 sale; 188 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by EyePoint, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
1 filing
1 insider, $52.3K in total
Open-market sells
1 filing
1 insider, $73.2K in total
Insiders trading
2
Net value
−$20.9K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for EyePoint, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for EyePoint, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Elston GeorgeChief Financial Officer64,953IndirectAug 24, 20266
Zaderej Karen L.Director49,100Aug 18, 20262
Duker Jay S.President and CEO9,594Jul 14, 20265
Ribeiro RamiroChief Medical Officer0Jul 2, 20267
Lurker NancyDirector294,346Jan 7, 20264
Hassan FredDirector–Jan 6, 20261
Ando GoranDirector13,150Jan 6, 20261
Dicicco Wendy FDirector9,967Jan 6, 20261
Landis John B.Director21,400Jan 6, 20261
Duty StuartDirector–Jan 6, 20261
Sanders Reginald J.Director–Jan 6, 20261
Cormorant Asset Management, LPOther: Former 10% Owner8,265,000IndirectDec 8, 20251
Chen BihuaOther: Former 10% Owner8,265,000IndirectDec 8, 20251
Cormorant Global Healthcare Master Fund, LPOther: Former 10% Owner8,265,000IndirectDec 8, 20251
Guyer David RDirector1,850Jul 16, 20240
Adamis Anthony PDirector4,000Jun 25, 20240
Paggiarino Dario A.Chief Medical Officer67,080Apr 2, 20240
Jones David ScottSVP & Chief Commercial Officer44,916Feb 13, 20240
Ocumension TherapeuticsDirector100,221Jan 16, 20240
Liu YeDirector100,221IndirectJan 16, 20240
Pine Michael CraigChief Corp Dev.&Strat. Officer13,662Jan 9, 20240
EW Healthcare Partners, L.P.10% Owner, Other: See footnotes 1 and 33,490,921IndirectSep 6, 20230
Essex Woodlands Fund IX-GP, L.P.10% Owner3,490,921IndirectSep 6, 20230
Essex Woodlands IX, LLC10% Owner3,490,921IndirectSep 6, 20230
EW Healthcare Partners-A, L.P.10% Owner, Other: See footnotes 1 and 33,490,921IndirectSep 6, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2026 (view filing)4:08 PM ETAug 18Same dayZaderej Karen L.DirectorPPurchase+10.6K$4.93+$52.3K+27.5%49.1K after
Jul 2, 2026 (view filing)4:03 PM ETJun 302 daysRibeiro RamiroChief Medical OfficerSSale−4.88K$15.01−$73.2K−100.0%0 after2 lots10b5-1
Apr 20, 2026 (view filing)Apr 173 daysRibeiro RamiroChief Medical OfficerSSale−2.44K$15.00−$36.6K−100.0%0 after10b5-1
Mar 16, 2026 (view filing)Mar 16Same dayDuker Jay S.President and CEOPPurchase+1.50K$13.15+$19.7K+1.5%100.7K after
Mar 5, 2026 (view filing)Mar 41 dayRibeiro RamiroChief Medical OfficerSSale−2.44K$17.87−$43.6K−100.0%0 after10b5-1
Feb 18, 2026 (view filing)Feb 171 dayRibeiro RamiroChief Medical OfficerSSale−2.44K$15.00−$36.6K−100.0%0 after10b5-1
Jan 7, 2026 (view filing)Jan 52 daysRibeiro RamiroChief Medical OfficerSSale−42.5K$17.10−$727.5K−100.0%0 after10b5-1
Dec 8, 2025 (view filing)4:03 PM ETDec 44 daysCormorant Asset Management, LP and 2 othersOther: Former 10% OwnerSSale−60.0K$15.70−$942.2K−0.7%8.27M after
Dec 5, 2025 (view filing)Dec 41 dayLurker NancyDirectorSSale−9.30K$15.11−$140.5K−4.3%206.5K after10b5-1
Dec 1, 2025 (view filing)Nov 26-285 daysLurker NancyDirectorSSale−700$14.95−$10.5K−0.3%215.8K after2 lots10b5-1
Nov 12, 2025 (view filing)Nov 111 dayRibeiro RamiroChief Medical OfficerSSale−2.72K$11.61−$31.6K−100.0%0 after10b5-1
May 19, 2025 (view filing)May 16-193 daysZaderej Karen L.DirectorPPurchase+10.0K$5.90+$59.0K+37.7%36.5K after2 lots
May 15, 2025 (view filing)May 14-151 dayZaderej Karen L.DirectorPPurchase+10.0K$5.45+$54.5K+60.6%26.5K after2 lots
Aug 21, 2024 (view filing)Aug 201 dayDicicco Wendy FDirectorPPurchase+2.57K$7.79+$20.0K+34.7%9.97K after
Aug 21, 2024 (view filing)Aug 21Same dayAndo GoranDirectorPPurchase+5.00K$7.95+$39.8K+61.3%13.2K after
Aug 21, 2024 (view filing)Aug 192 daysZaderej Karen L.DirectorPPurchase+12.5K$7.98+$99.8K+312.5%16.5K after
Aug 20, 2024 (view filing)Aug 164 daysLurker NancyDirectorPPurchase+3.17K$7.88+$25.0K+3.4%97.6K after
Jul 16, 2024 (view filing)Jul 124 daysGuyer David RDirectorSSale−11.6K$10.06−$116.9K−86.3%1.85K after10b5-1
Jun 4, 2024 (view filing)Jun 31 dayGuyer David RDirectorSSale−11.6K$10.30−$119.7K−75.9%3.70K after10b5-1
May 16, 2024 (view filing)May 142 daysGuyer David RDirectorSSale−11.6K$12.65−$147.1K−67.7%5.55K after10b5-1
May 8, 2024 (view filing)4:23 PM ETMay 62 daysCormorant Asset Management, LP and 2 others10% OwnerPPurchase+850.0K$11.86+$10.1M+11.4%8.32M after2 lots
Apr 22, 2024 (view filing)4:00 PM ETApr 184 daysCormorant Asset Management, LP and 2 others10% OwnerPPurchase+581.8K$18.03+$10.5M+8.4%7.47M after2 lots
Feb 5, 2024 (view filing)Feb 23 daysJones David ScottSVP & Chief Commercial OfficerSSale−209$28.49−$5.95K−0.5%38.0K after10b5-1
Jan 30, 2024 (view filing)Jan 264 daysPaggiarino Dario A.Chief Medical OfficerSSale−49.3K$25.66−$1.27M−57.5%36.5K after3 lots10b5-1
Jan 29, 2024 (view filing)Jan 263 daysJones David ScottSVP & Chief Commercial OfficerSSale−26.0K$25.38−$660.4K−40.7%38.0K after2 lots10b5-1
Jan 29, 2024 (view filing)Jan 254 daysPaggiarino Dario A.Chief Medical OfficerSSale−600$25.00−$15.0K−1.6%36.5K after2 lots10b5-1
Jan 26, 2024 (view filing)Jan 24-252 daysJones David ScottSVP & Chief Commercial OfficerSSale−11.9K$25.01−$297.6K−23.9%38.0K after4 lots10b5-1
Jan 25, 2024 (view filing)Jan 23-242 daysPaggiarino Dario A.Chief Medical OfficerSSale−16.4K$25.01−$409.8K−31.0%36.5K after4 lots
Jan 25, 2024 (view filing)Jan 23-242 daysLurker NancyExecutive Vice ChairSSale−35.0K$24.98−$874.2K−20.5%135.4K after2 lots10b5-1
Jan 24, 2024 (view filing)Jan 22-232 daysJones David ScottSVP & Chief Commercial OfficerSSale−35.1K$22.68−$795.3K−48.0%38.0K after4 lots
Jan 16, 2024 (view filing)Jan 115 daysOcumension TherapeuticsDirectorSSale−1.91M$19.45−$37.2M−95.0%100.2K afterDuplicate filing
Jan 16, 2024 (view filing)Jan 115 daysLiu YeDirectorSSaleCommon Stock, $0.001 par value−1.91M$19.45−$37.2M−95.0%100.2K after
Jan 11, 2024 (view filing)4:00 PM ETJan 9-112 daysCormorant Asset Management, LP and 2 others10% OwnerPPurchase+855.0K$19.94+$17.1M+14.2%6.89M after2 lots
Jan 10, 2024 (view filing)Jan 82 daysPaggiarino Dario A.Chief Medical OfficerSSale−22.9K$21.13−$484.2K−38.6%36.5K after10b5-1
Dec 15, 2023 (view filing)Dec 132 daysPaggiarino Dario A.Chief Medical OfficerSSale−1.46K$20.00−$29.2K−5.4%25.7K after10b5-1
Dec 12, 2023 (view filing)4:52 PM ETDec 84 daysCormorant Asset Management, LP and 2 others10% OwnerPPurchase+588.2K$17.00+$10.0M+10.8%6.04M after
Dec 11, 2023 (view filing)Dec 47 daysPine Michael CraigChief Corp Dev.&Strat. OfficerSSale−46.0K$21.97−$1.01M−91.4%4.34K afterAmended2 lots10b5-1
Dec 7, 2023 (view filing)Dec 5-62 daysOcumension TherapeuticsDirectorSSale−1.00M$19.51−$19.5M−33.2%2.01M after2 lotsDuplicate filing
Dec 7, 2023 (view filing)Dec 5-62 daysLiu YeDirectorSSaleCommon Stock, $0.001 par value−1.00M$19.51−$19.5M−33.2%2.01M after2 lots
Dec 6, 2023 (view filing)4:39 PM ETDec 42 daysCormorant Asset Management, LP and 2 others10% OwnerPPurchase+1.92M$21.82+$41.9M+54.3%5.45M after17 lots
Dec 6, 2023 (view filing)Dec 42 daysPaggiarino Dario A.Chief Medical OfficerSSale−30.6K$22.00−$673.8K−54.4%25.7K after10b5-1
Dec 6, 2023 (view filing)Dec 42 daysLurker NancyExecutive Vice ChairSSale−20.0K$20.76−$415.2K−10.5%170.6K after10b5-1
Sep 6, 2023 (view filing)7:10 PM ETSep 15 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 3SSaleCommon Stock, $0.001 par value−20.0K$9.90−$198.0K−0.6%3.49M afterAmended
Sep 1, 2023 (view filing)4:51 PM ETAug 30-312 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 6SSaleCommon Stock, $0.001 par value−139.5K$10.54−$1.47M−3.8%3.51M after4 lots
Aug 30, 2023 (view filing)5:46 PM ETAug 28-292 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 4SSaleCommon Stock, $0.001 par value−148.7K$11.14−$1.66M−3.9%3.65M after3 lots
Aug 30, 2023 (view filing)5:32 PM ETAug 24-256 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 6SSaleCommon Stock, $0.001 par value−223.9K$11.11−$2.49M−5.6%3.80M afterAmended4 lots
Aug 24, 2023 (view filing)5:30 PM ETAug 22-232 daysEW Healthcare Partners, L.P. and 3 others10% Owner, Other: See footnotes 1 and 2SSaleCommon Stock, $0.001 par value−167.9K$13.49−$2.26M−4.0%4.02M after2 lots
May 31, 2023 (view filing)May 301 dayLiu YeDirectorSSaleCommon Stock, $0.001 par value−1$6.00−$60.0%3.01M after
Mar 15, 2022 (view filing)Mar 141 dayPine Michael CraigChief Corp Dev.&Strat. OfficerPPurchase+1.00K$12.21+$12.2KNew position1.00K after
Nov 17, 2021 (view filing)Nov 152 daysLurker NancyPresident & CEOSSale−10.0K$20.15−$201.5K−8.8%103.5K after